ImmunityBio (IBRX) Ownership - Who Owns ImmunityBio?

2,506 Followers

ImmunityBio (IBRX) Ownership Overview

62.91% Insiders

4.06% Mutual Funds

2.62% Other Institutional Investors

6.45% ETFs

23.96% Public Companies and Individual Investors

The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 13.13% of the company’s stock is owned by Institutional Investors, 62.91% is owned by Insiders, and 23.96% is owned by Public Companies and Individual Investors.

The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 6.69% of the company’s stock is owned by Institutional Investors, 62.91% is owned by Insiders, and 6.45% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 02, 2026	Shiong Patrick Soon	xxxxxxxxxxxxx	$24967750

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$26441144
Mar 31, 2024	Goalvest Advisory Llc	xxxxxxxxxxxxx	$3835
Mar 31, 2024	Stilwell Value Llc	xxxxxxxxxxxxx	$613600
Mar 31, 2024	Clough Capital Partners L P	xxxxxxxxxxxxx	$721294

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	654,612,336	Insider	62.50%	5,105,976,221
	31,079,310	Institution	2.97%	242,418,618
	27,688,648	Institution	2.64%	215,971,454
	16,486,786	Institution	1.57%	128,596,931
	12,631,087	Institution	1.21%	98,522,479
	3,451,428	Institution	0.33%	26,921,138
Michael Rockefeller	3,447,346	Institution	0.33%	26,889,299
	3,144,913	Institution	0.30%	24,530,321
	2,827,788	Insider	0.27%	22,056,746
	1,747,009	Institution	0.17%	13,626,670

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
27,688,648	Institution	2.64%	215,971,454
3,451,428	Institution	0.33%	26,921,138
3,144,913	Institution	0.30%	24,530,321
1,747,009	Institution	0.17%	13,626,670
998,884	Institution	0.10%	7,791,295
995,597	Institution	0.10%	7,765,657
929,984	Institution	0.09%	7,253,875
886,389	Institution	0.08%	6,913,834
465,000	Institution	0.04%	3,627,000
395,431	Institution	0.04%	3,084,362

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
SPDR S&P BIOTECH ETF	12,597,398	Institution	1.20%	92,212,953
Vanguard Total Stock Market ETF	11,496,928	Institution	1.10%	86,456,899
Vanguard Small-Cap ETF	8,288,977	Institution	0.79%	62,333,107
iShares Russell 2000 ETF	6,919,459	Institution	0.66%	53,971,780
Vanguard Small-Cap Growth ETF	4,648,418	Institution	0.44%	34,956,103
Vanguard Extended Market ETF	3,457,550	Institution	0.33%	26,000,776
iShares Biotechnology ETF	2,615,380	Institution	0.25%	20,399,964
iShares Russell 2000 Growth ETF	2,006,749	Institution	0.19%	15,652,642
Schwab U.S. Small-Cap ETF	1,543,237	Institution	0.15%	11,296,495
Vanguard Russell 2000 ETF	1,517,355	Institution	0.14%	11,410,510

FAQ

Who Owns Immunitybio Inc (IBRX)?

According to the latest TipRanks data, approximately 2.62% of the company's stock is held by institutional investors, 62.91% is held by insiders, and 23.96% is held by retail investors.

What percentage of Immunitybio Inc (IBRX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.62% of Immunitybio Inc (IBRX) stock is held by institutional investors.

What percentage of Immunitybio Inc (IBRX) stock is held by retail investors?

According to the latest TipRanks data, approximately 23.96% of Immunitybio Inc (IBRX) stock is held by retail investors.

Who owns the most shares of Immunitybio Inc (IBRX)?

Shiong Patrick Soon owns the most shares of Immunitybio Inc (IBRX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.